AKAN logo

Akanda (AKAN)

Profile

Full Name

Akanda Corp.

Ticker Symbol

AKAN

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United Kingdom

IPO

March 15, 2022

Indexes

Not included

Website

http://www.akandacorp.com

Employees

46

Key Details

Price

$1.10(-1.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.16M(-17.54% YoY)

Annual EPS

-$572.80(-85.49% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.10
AKAN price is $1.10

30-Day Relative Volume

0.88
AKAN 30-day relative volume is 0.88

Price Performance

Price Most recent change

-1.79%
AKAN price was down -1.79% on Apr 17, 2025

Price YTD change

-31.25%
AKAN price is down -31.25% since January 1st

Price 1-year change

-73.81%
AKAN price is down -73.81% year-on-year

Price 3-year change

-99.97%
AKAN price is down -99.97% over the past 3 years

Price Range

Price All-time high

$12400.00
AKAN price is currently -99.99% below its historical high of $12400.00

Price 3-year low

$0.71
AKAN price is currently +54.93% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.57M
AKAN market capitalization is $1.57 million

Market cap 3-year change

-98.9%
AKAN market capitalization is down -98.9% over the past 3 years

Market cap All-time high

$170.54M
AKAN market capitalization is currently -99.08% below its historical high of $170.54 million

Market cap sector rank

6.09%
AKAN market capitalization is higher than 6.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+856.94%
AKAN shares outstanding is up +856.94% year-on-year

Shares Outstanding 3-Year Change

+3852.35%
AKAN shares outstanding is up +3852.35% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
AKAN beta is 1.11

200-day SMA

$1.46
AKAN price is currently -24.66% below its 200-day simple moving average

50-day SMA

$1.49
AKAN price is currently -26.17% below its 50-day simple moving average

RSI

28.45
AKAN 14-day relative strength index is 28.45

Volume

0.88
AKAN 30-day relative volume is 0.88

ATR

$0.08
AKAN average true range is $0.08

10-day Historical Volatility

64.46%
AKAN 10-day historical volatility is 64.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.16M
AKAN annual revenue is $2.16 million

Revenue Analysts estimate

-
AKAN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-17.54%
AKAN annual revenue is down -17.54% year-on-year

Revenue Sector rank

15.92%
AKAN annual revenue is higher than 15.92% of companies in Healthcare sector

EPS

EPS

-$572.80
AKAN annual earnings per share is -$572.80

EPS Analysts estimate

-
AKAN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-85.49%
AKAN annual earnings per share is down -85.49% year-on-year

EPS Sector rank

0.75%
AKAN annual earnings per share is higher than 0.75% of companies in Healthcare sector

Profit

Gross profit

$111.40K
AKAN annual gross profit is $111.40 thousand

Gross margin

5.16%
AKAN annual gross profit margin is 5.16%

Operating profit

-$10.05M
AKAN annual operating income is -$10.05 million

Operating margin

-465.33%
AKAN annual operating profit margin is -465.33%

Net income

-$32.28M
AKAN annual net profit is -$32.28 million

Net margin

-1494.18%
AKAN annual net profit margin is -1494.18%

Expenses

Total expenses

$12.21M
AKAN annual total expenses is $12.21 million

Operating expenses

$10.16M
AKAN annual total operating expenses is $10.16 million

Cost of goods sold

$2.05M
AKAN annual cost of goods sold is $2.05 million

Selling, general & administrative expenses

$5.88M
AKAN annual SGA is $5.88 million

Depreciation and amortization

$4.28M
AKAN annual depreciation & amortization is $4.28 million

Interest expense

$255.70K
AKAN annual interest expense is $255.70 thousand

Income tax

-
AKAN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$32.02M
AKAN annual earnings before interest & taxes is -$32.02 million

EBITDA

-$27.74M
AKAN annual EBITDA is -$27.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$8.84M
AKAN annual total assets is $8.84 million

Non current assets

$7.03M
AKAN annual long term assets is $7.03 million

Current assets

$1.81M
AKAN annual total current assets is $1.81 million

Cash and cash equivalents

$82.80K
AKAN annual cash & cash equivalents is $82.80 thousand

Accounts receivable

$155.80K
AKAN annual accounts receivable is $155.80 thousand

Inventory

$1.29M
AKAN annual inventory is $1.29 million

Liabilities

Total liabilities

$12.67M
AKAN annual total liabilities is $12.67 million

Long term liabilities

$2.50M
AKAN annual total long term liabilities is $2.50 million

Current liabilities

$10.17M
AKAN annual total current liabilities is $10.17 million

Accounts payable

$6.01M
AKAN annual accounts payable is $6.01 million

Debt

Total debt

$4.00M
AKAN annual total debt is $4.00 million

Total debt 1-year change

+2.54%
AKAN annual total debt is up +2.54% year-on-year

Long term debt

$2.50M
AKAN annual long term debt is $2.50 million

Short term debt

$1.50M
AKAN annual short term debt is $1.50 million

Equity & Capital

Shareholders equity

-$3.83M
AKAN annual stockholders equity is -$3.83 million

Book value

-$3.83M
AKAN annual book value is -$3.83 million

Retained earnings

-$53.36M
AKAN annual retained earnings is -$53.36 million

Working capital

-$8.37M
AKAN annual working capital is -$8.37 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.50M
AKAN annual cash flow from operations is -$1.50 million

Cash from operations 1-year change

+86.92%
AKAN annual cash flow from operations is up +86.92% year-on-year

Cash from investing

$24.90K
AKAN annual cash flow from investing activities is $24.90 thousand

Cash from investing 1-year change

+100.59%
AKAN annual cash flow from investing activities is up +100.59% year-on-year

Cash from financing

$1.49M
AKAN annual cash flow from financing activities is $1.49 million

Cash from financing 1-year change

-89.49%
AKAN annual cash flow from financing activities is down -89.49% year-on-year

CAPEX

CAPEX

$1500.00
AKAN annual capital expenditures is $1500.00

CAPEX 1-year change

-99.52%
AKAN annual capital expenditures is down -99.52% year-on-year

Free Cash Flow

Free cash flow

-$1.50M
AKAN annual free cash flow is -$1.50 million

Free cash flow 1-year change

+87.25%
AKAN annual free cash flow is up +87.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

5.16%
AKAN annual gross profit margin is 5.16%

Operating margin

-465.33%
AKAN annual operating profit margin is -465.33%

Net margin

-1494.18%
AKAN annual net profit margin is -1494.18%

ROA & ROE

ROA

-134.94%
AKAN annual return on assets is -134.94%

ROE

-279.79%
AKAN annual return on equity is -279.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AKAN price to earnings ratio value is unknown

PE ratio Sector rank

-
AKAN price to earnings ratio is unknown

PB Ratio

PB ratio

0.34
AKAN price to book ratio is 0.34

PB ratio Sector rank

24.73%
AKAN price to book ratio is higher than 24.73% of companies in Healthcare sector

PS Ratio

PS ratio

-
AKAN price to sales ratio value is unknown

PS ratio Sector rank

-
AKAN price to sales ratio is unknown

Enterprise value

Enterprise value

-$4.07M
AKAN enterprise value is -$4.07 million

Enterprise value Sector rank

6.86%
AKAN enterprise value is higher than 6.86% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
AKAN EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
AKAN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.18
AKAN annual current ratio is 0.18

Quick ratio

0.05
AKAN annual quick ratio is 0.05

Leverage

Debt to equity

-1.01
AKAN annual debt to equity ratio is -1.01

Interest coverage ratio

-125.22
AKAN annual interest coverage ratio is -125.22

Risk & Stability

Piotroski F-Score

-
AKAN piotroski f-score value is unknown

Altman Z-Score

-21.22
AKAN altman z-score is -21.22

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Polyrizon (PLRZ)
HSDT logo
Helius Medical Technologies (HSDT)
ONCT logo
Oncternal Therapeutics (ONCT)
AVGR logo
Avinger (AVGR)
FOXO logo
FOXO Technologies (FOXO)
YCBD logo
cbdMD (YCBD)
VINC logo
Vincerx Pharma (VINC)
Scinai Immunotherapeutics (SCNI)
PBM logo
Psyence Biomedical (PBM)
  • What is the ticker symbol for Akanda?
  • Does Akanda pay dividends?
  • What sector is Akanda in?
  • What industry is Akanda in?
  • What country is Akanda based in?
  • When did Akanda go public?
  • Is Akanda in the S&P 500?
  • Is Akanda in the NASDAQ 100?
  • Is Akanda in the Dow Jones?
  • When does Akanda report earnings?

What is the ticker symbol for Akanda?

The ticker symbol for Akanda is NASDAQ:AKAN

Does Akanda pay dividends?

No, Akanda does not pay dividends

What sector is Akanda in?

Akanda is in the Healthcare sector

What industry is Akanda in?

Akanda is in the Drug Manufacturers - Specialty & Generic industry

What country is Akanda based in?

Akanda is headquartered in United Kingdom

When did Akanda go public?

Akanda's initial public offering (IPO) was on March 15, 2022

Is Akanda in the S&P 500?

No, Akanda is not included in the S&P 500 index

Is Akanda in the NASDAQ 100?

No, Akanda is not included in the NASDAQ 100 index

Is Akanda in the Dow Jones?

No, Akanda is not included in the Dow Jones index

When does Akanda report earnings?

The date for Akanda's next earnings report has not been announced yet
On this page